The roles of the Hippo pathway in cancer metastasis

被引:92
|
作者
van Rensburg, Helena J. Janse [1 ]
Yang, Xiaolong [1 ]
机构
[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada
关键词
Hippo pathway; Tumour suppressor; Metastasis; EMT; Cell migration; Cancer; YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; REGULATES CELL-PROLIFERATION; BREAST-CANCER; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; UP-REGULATION; LUNG-CANCER; E-CADHERIN; TRANSCRIPTIONAL COACTIVATOR;
D O I
10.1016/j.cellsig.2016.08.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer metastasis refers to the sequence of events whereby tumour cells detach from their primary tissue, invade and migrate to nearby vasculature, intravasate into circulation, survive in circulation and extravasate at a distant site to establish a secondary tumour. Each step in this "metastatic cascade" is coordinated by complex molecular events that remain only incompletely understood. Given that the vast majority of cancer fatalities occur due to metastasis, there is an urgent need for an improved understanding of the specific mechanisms underlying cancer metastasis and for the development of therapeutics targeting this lethal process. The Hippo pathway is an emerging signaling pathway that plays important roles in development and disease. In cancer cells, dysregulation of the Hippo pathway drives multiple aspects of tumour initiation and progression. Recent studies have uncovered a role for the Hippo pathway core components in promoting cancer metastasis. In this review, we summarize the clinical and biochemical evidence implicating the Hippo pathway in metastasis. Additionally, we describe the molecular mechanisms by which aberrant Hippo signaling promotes metastasis. Finally, we highlight areas for future research. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1761 / 1772
页数:12
相关论文
共 50 条
  • [31] Two faces of Hippo: activate or suppress the Hippo pathway in cancer
    Cao, Jingwen
    Huang, Wenlong
    ANTI-CANCER DRUGS, 2017, 28 (10) : 1079 - 1085
  • [32] LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
    Dahu Chen
    Yutong Sun
    Yongkun Wei
    Peijing Zhang
    Abdol Hossein Rezaeian
    Julie Teruya-Feldstein
    Sumeet Gupta
    Han Liang
    Hui-Kuan Lin
    Mien-Chie Hung
    Li Ma
    Nature Medicine, 2012, 18 : 1511 - 1517
  • [33] LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
    Chen, Dahu
    Sun, Yutong
    Wei, Yongkun
    Zhang, Peijing
    Rezaeian, Abdol Hossein
    Teruya-Feldstein, Julie
    Gupta, Sumeet
    Liang, Han
    Lin, Hui-Kuan
    Hung, Mien-Chie
    Ma, Li
    NATURE MEDICINE, 2012, 18 (10) : 1511 - U105
  • [34] The Hippo signaling pathway in gastric cancer
    Cao, Zhifa
    An, Liwei
    Han, Yi
    Jiao, Shi
    Zhou, Zhaocai
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (06) : 893 - 903
  • [35] The Hippo Signaling Pathway in Pancreatic Cancer
    Ansari, Daniel
    Ohlsson, Henrik
    Althini, Carl
    Bauden, Monika
    Zhou, Qimin
    Hu, Dingyuan
    Andersson, Roland
    ANTICANCER RESEARCH, 2019, 39 (07) : 3317 - 3321
  • [36] Regulators of mammalian Hippo pathway in cancer
    Liu, Angela M.
    Wong, Kwong-Fai
    Jiang, Xiaoou
    Qiao, Yiting
    Luk, John M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (02): : 357 - 364
  • [37] The Hippo signaling pathway in regeneration and cancer
    Tollot M.
    Vranesic A.C.
    von Eyss B.
    BIOspektrum, 2020, 26 (2) : 154 - 157
  • [38] The Hippo pathway in normal development and cancer
    Maugeri-Sacca, Marcello
    De Maria, Ruggero
    PHARMACOLOGY & THERAPEUTICS, 2018, 186 : 60 - 72
  • [39] Regulation of the Hippo pathway in cancer biology
    Moon, Sungho
    Park, So Yeon
    Park, Hyun Woo
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (13) : 2303 - 2319
  • [40] The Hippo Signaling Pathway in Development and Cancer
    Pan, Duojia
    DEVELOPMENTAL CELL, 2010, 19 (04) : 491 - 505